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Abstract
Background: Diabetes mellitus (DM) is an independent risk factor for atrial fibrillation
(AF). However, the underlying mechanisms are still not clearly elucidated. The aim of this
study was to evaluate the atrial electromechanical function, atrial electrophysiological changes
and AF inducibility in alloxan-induced diabetic rabbits.
Methods: In 8 alloxan-induced diabetic rabbits and 8 controls, we evaluated atrial
electromechanical function by tissue Doppler imaging. Isolated Langendorff-perfused rabbit
hearts were prepared to measure atrial refractory effective period (AERP) and its dispersion
(AERPD), interatrial conduction time (IACT) and vulnerability to AF. Atrial interstitial
fibrosis was evaluated by Sirius-Red staining.
Results: Compared with controls, left atrial lateral wall Pa’-start interval (Pastart) and right
atrial wall Pastart were increased in diabetic rabbits. AERPD was increased and IACT was
prolonged in diabetic rabbits. Inducibility of AF in diabetic group was significant higher than
controls (6/8 vs. 1/8, p < 0.05). Extensive interstitial fibrosis was observed in the DM group
(p < 0.01). Correlation analysis showed that right atrial wall Pastart, Pa’-peak interval (Papeak)
and total electromechanical activity (TEMA); left atrial lateral wall Papeak and TEMA, left
atrial posterior wall TEMA, and IACT were correlated with atrial areas of fibrosis.
Conclusions: Atrial electromechanical function is impaired in diabetic rabbits, and is
associated with atrial fibrosis and interatrial electrical conduction delay. (Cardiol J 2013; 20,
1: 59–67)
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Introduction
Atrial fibrillation (AF) remains the most common
clinically encountered arrhythmia associated with in-
creased morbidity and mortality [1]. Diabetes mellitus
(DM) has been reported as one of the strongest inde-
pendent risk factors for AF and atrial flutter with an
odds ratio of 1.4–2.2 [2–4] and its prevalence in AF
patients is 10–25% [5]. On the other hand, DM is one
of the most common chronic diseases with increasing
prevalence of approximately 140 million people world-
wide. This number is projected to increase to 300 mil-
lion by the year of 2025 [6]. However, the pathophys-
iological pathways linking DM and AF remain obscure.
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The intra- and interatrial electromechanical
delay (EMD) and the inhomogeneous propagation
of sinus impulses are well-known electrophysiolo-
gical characteristics of atrial remodeling that facili-
tate the development of AF. This issue has been
evaluated non-invasively by several alternative
techniques such as P-wave dispersion and tissue
Doppler imaging (TDI) [7, 8]. However, data on the
potential relationship between atrial EMD evaluat-
ed by TDI, atrial electrophysiological changes and
AF promotion are sparse. The purpose of this study
was to evaluate atrial EMD, left atrial (LA) mechan-
ical functions, atrial electrophysiological changes
and AF promotion, as well as to investigate wheth-
er atrial EMD and LA mechanical functions are re-
lated to atrial electrophysiological changes and AF
promotion in alloxan-induced diabetic rabbits.
Methods
We obtained experimental animal use approv-
al by the Experimental Animal Administration Com-
mittee of Tianjin Medical University and Tianjin
Municipal Commission for Experimental Animal
Control, which follow the guidelines established by
the U.S. National Institutes of Health.
Experimental animals
Sixteen Japanese rabbits (1.5–2.0 kg at the
beginning of the study) (Beijing Medical Animals
Research Institute, Beijing, China) were used in this
study and divided into two groups: DM group (n = 8)
and control group (n = 8). In the DM group, allox-
an monohydrate (Sigma Aldrich Chemical, Saint
Louis, MO, USA) was dissolved in sterile normal
saline to achieve a concentration of 5% (W/V), and
120 mg/kg was immediately administered intrave-
nously via the marginal ear vein over a period of
2 min with a 25 gauge butterfly catheter. The dia-
betic state was examined 48 h later by quantitative
determination of blood glucose levels of ≥ 14 mmol/L.
Then, blood glucose concentration was monitored
weekly with a glucometer Optium Xceed (Abbott
Laboratories Medisense Products, Bedford, MA,
USA). The animals in both groups were housed in
cages in the Tianjin Institute of Cardiology under
a 12 h light cycle, constant temperature and humi-
dity, while they had free access to water and a stan-
dard laboratory pellet diet for 8 weeks.
Echocardiographic examination
After 8 weeks, echocardiographic images were
obtained after inducing general anesthesia with 3%
pelltobarbitalum natricum (10 mg/kg). Rabbits were
placed on the table at the left lateral decubitus po-
sition. The echocardiograms were obtained using
a GE Vingmed machine (Vivid 7/Vingmed General
Electric, Milwaukee, WI) equipped with a 7.5 MHz
standard pediatric probe. Parasternal and apical
views were obtained with the probe positioned at
a cranial angle over a shaved area on the lower por-
tion of the thoracic wall as previously reported [9,
10]. The exact position of the transducer was ad-
justed as necessary to acquire standard images.
Standard parasternal short- and long-axis views as
well as apical 2-, 3- and 4-chamber views acquired
with at least 200 frames per second were digitized
during 5 consecutive cardiac cycles in cine-loop for-
mat for analysis. Echocardiographic measurements
by both 2D and M-mode were obtained in the
parasternal long axis view. These included inter-
ventricular septal thickness (IVST) and left ventri-
cular posterior wall thickness (LVPWT), left ventri-
cular end-diastolic dimension and end-systolic di-
mension, aortic root and left atrial anteroposterior
diameter. Doppler imaging of the mitral valve was
obtained from the apical 4-chamber view. The fol-
lowing measurements were obtained at the mitral
inflow velocity image: peak E and peak A wave ve-
locities, E/A ratio. Measurements of left ventricu-
lar ejection fraction (LVEF) according to interna-
tional standards [11]. The average of the 3 measure-
ments was used for subsequent analysis.
Atrial mechanical functions
Atrial mechanical functions comprised LA dia-
meter measured from the parasternal long axis; all
volume measurements were calculated from apical
4- and 2-chamber views using the biplane area-length
method. Right atrial (RA) and LA maximal volume
(immediately before the mitral valve opening), LA
and RA minimal volume (at mitral valve closure), and
LA and RA P-wave volume (RA and LA volumes at
the beginning of the P-wave) were measured. LA and
RA ejection fractions were calculated according to
the formula (maximal volume – minimal volume)/
/maximal volume. LA and RA active emptying values
were calculated as (volume at P-wave – minimal
volume)/volume at P-wave [12–14].
Atrial electromechanical functions
The TDI tracing was recorded over 5 cardiac
cycles and was used for offline calculations. The
different atrial walls were identified from the same
apical views as follows: the RA wall, the interatrial
septum, and the LA lateral wall from the apical
4-chamber view; the LA inferior wall and the LA
anterior wall from the apical 2-chamber view; and
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the LA posterior wall (post) from the apical 3-cham-
ber view. Each atrial wall was studied at mid levels,
placing a 1 mm sample volume at the mid portion
of each atrial wall. The regional electromechanical
function at each atrial wall was studied by the fol-
lowing time intervals. The Pa’-start interval
(Pastart) was defined as the time between the be-
ginning of the P-wave on the monitor’s electrocar-
diogram (ECG) (lead II) to the start of the a’ wave
on the TDI-curve profile. The Pa’-peak interval
(Papeak) was the time between the beginning of the
P-wave on the monitor’s ECG to the peak of the
a’ wave on the TDI-curve profile. The a’-wave du-
ration (a-dur) was the time from the beginning to
the end of the a’ wave on the TDI-curve profile. The
total electromechanical activity (TEMA) was the
time between the beginnings of the P-wave on the
monitor ECG to the end of the a’ wave on the TDI-
-curve profile. Expressions of atrial electromechani-
cal function shown in Figure 1.
Hemodynamic studies
At 8 weeks, the rabbits were intravenously
heparinized (1000 IU) and anesthetized with 3%
pelltobarbitalum natricum (30 mg/kg). The ECG
tracing was obtained with bipolar cutaneous elec-
trodes placed on all 4 limbs and the signal was am-
plified and filtered. The right carotid artery was iso-
lated surgically with a median incision in the neck.
Cannulae was inserted into the right carotid artery
to monitor aortic systolic and diastolic blood pres-
sure (SBP, DBP). SBP and DBP (3 times, 20 s in-
terval) were recorded after a stabilization period of
5–10 min. Then the cannulae was moved slowly
through the aortic valve to left ventricle to measure
left ventricle end-diastolic pressure (LVEDP). The
ECG and BP were continuously monitored on cus-
tom-made computer software program (Electro-
physiological Recording System, TOP-2001,
HTONG Company, Shanghai, China).
Electrophysiological studies
Following the hemodynamic studies, the rab-
bit hearts were quickly removed and placed in cold
perfusion fluid (4oC). The aorta was cannulated and
connected to a Langendorff perfusion system filled
with warmed (37 ± 0.5oC) Tyrode’ s solution. The
perfusion pressure was maintained at 65–75 mm Hg,
resulting in an initial coronary flow of 50 to
60 mL/min. The Tyrode’s solution consisted of the
following (mmol/L): NaCl 130, KCl 5.6, NaHCO3
24.2, CaCl2 2.2, MgCl2 0.6, NaH2PO4 1.2, and glu-
cose 12. The solution reservoir was saturated with
95% O2 and 5% CO2 and had a pH of 7.4.
Four sets of silver bipolar electrodes were
placed on the epicardial surface of high right
Figure 1. Representatives of measurements on atrial electromechanical function. Pastart was the time interval from
the onset of P wave on surface electrocardiogram (ECG) to the beginning of the a’ wave on the TDI-curve profile;
Papeak was the time interval from the onset of P wave on surface ECG to the peak of the a’ wave on the TDI-curve
profile; The a’-wave duration was the time from the beginning to the end of the a’ wave on the TDI-curve profile. The
total electromechanical activity was the time between the beginnings of the P-wave on the monitor ECG to the end of
the a’ wave on the TDI-curve profile.
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atrium (HRA), high left atrium (HLA), left atrial ap-
pendage and right ventricular apex. The atrial ef-
fective refractory period (AERP) was evaluated
using programmed extra-stimuli and defined as the
longest S1–S2 interval that failed to capture. The
S2 extra-stimulus was delivered after a drive-train
of 8 S1 stimuli of 250 ms. The S1–S2 interval was
decreasing in intervals of 2 ms until atrial refracto-
riness was reached (pulse duration: 2 ms, output:
2-fold diastolic pacing threshold). AERP dispersion
(AERPD) was defined as the difference between the
longest AERP and the shortest AERP at 4 differ-
ent sites. Wenckebach cycle length of atrial-ventric-
ular conduction was measured by RA incremental
pacing. The interatrial conduction time (IACT) was
measured during HRA (at a pacing cycle length of
250 ms) pacing. IACT was defined as the duration
from the HRA pacing stimulus to the beginning of
HLA stimulus. AF vulnerability was tested by the
burst pacing (cycle length of 50 ms) for 1 s, 5 times
at 30 s interval at an amplitude of 5 V. We evaluat-
ed the appearance of AF, defined as rapid, irregu-
lar atrial response longer than 1000 ms. All epi-
cardial ECG were amplified with a custom-made
amplifier and recorded with a custom-made com-
puter software program (Electrophysiological Re-
cording System, TOP-2001, HTONG Company,
Shanghai, China).
Histological studies
Isolated atrial samples from the LA free wall
was placed in 4% paraformaldehyde, embedded in
paraffin, and cut into 4 µm cross-sections. Sirius-
-Red (Sigma Aldrich) staining was used to evaluate
interstitial fibrosis. We randomly selected 40 sec-
tions from 8 rabbits per group and evaluated them
at 200-fold magnification.The vascular and perivas-
cular fibrosis were excluded from the selected sec-
tions. The red pixel content of digitized images was
detected as interstitial fibrotic area and measured
relative to total tissue area with a digital imaging
analyzer of Image Pro Plus 4.5 Scion image software
(Scion corporation, Frederick, MD), these analyses
were performed in a blind manner. The result was
obtained from 2 independent measurements.
Statistical analyses
Data are presented as mean ± standard devia-
tion (SD). Statistical analysis was done using the
Student’s t-test (unpaired). The incidence of AF was
analyzed by Fisher’s exact test. Statistical differenc-
es were considered significant at a p value < 0.05.
For the exploration of relationships between TDI
parameters, electrophysiological parameters and
atrial interstitial fibrosis, we calculated Pearson’s
correlation coefficients.
Results
Echocardiographic characteristics
Left atrial mechanical functions. LA vo-
lume parameters are presented in Table 1. Both
groups were similar with respect to maximum LA
volume, LA passive emptying volume, LA passive
emptying fraction and LA total emptying volume.
However, LA diameter, IVST, LVPWT were sig-
nificantly increased in DM group compared with
controls.
Atrial electromechanical function. The atri-
al electromechanical function parameters measured
from different sites by TDI are shown in Table 2.
RA Pastart, LA lateral wall Pastart, LA lateral wall
Papeak and LA posterior wall TEMA were greater
in the DM group compared with controls (p < 0.05).
Pastarts and Papeaks in other atrial walls tended
to increase in DM group, but they did not reach sta-
tistical significance.
Hemodynamic parameters
As shown in Table 3, the DBP and LVEDP
were slightly increased in DM group. However, no
significant differences were observed between the
2 groups.
Electrophysiological studies
As shown in Table 3, in both the RA and the
LA, the AERPs in DM group were slightly pro-
longed. However, no significant differences were
observed between the 2 groups. AERPD was sig-
nificantly increased in DM group (p < 0.001). IACT
in diabetic rabbits was significantly prolonged com-
pared with healthy controls. Figure 2A shows rep-
resentative AF induced by the burst pacing, which
were observed in the DM group; Figure 2B shows
the inducibility of AF in both groups. AF was in-
duced in 6/8 (75%) of animals in DM group, where-
as 1/8 (12.5%) in controls (p < 0.05).
Atrial interstitial fibrosis
Figure 3A and B illustrates the representative
LA histology in both groups and the quantitative
ratio of the area of fibrosis to the area of the refer-
ence tissue is summarized in Figure 3C. Compared
with the control group, extensive and heteroge-
neous interstitial fibrosis was observed in the DM
group (2.09 ± 0.7% vs. 6.67 ± 2.3%, p < 0.01).
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Table 2. Atrial electromechanical function assessed by Doppler tissue echocardiography.
DM group (n = 8) Control group (n = 8) P
Right atrial wall
Pastart [ms] 60.44 ± 20.49 40.50 ± 12.87 0.032
Papeak [ms] 82.44 ± 24.53 62.12 ± 18.26 0.075
TEMA [ms] 102.44 ± 20.59 91.75 ± 19.19 0.287
Left atrial lateral wall
Pastart [ms] 60.55 ± 14.36 39.75 ± 18.32 0.019
Papeak [ms] 83.00 ± 11.02 59.75 ± 20.09 0.009
TEMA [ms] 106.33 ± 15.43 92.62 ± 20.80 0.141
The interatrial septum
Pastart [ms] 54.66 ± 21.02 46.87 ± 21.78 0.465
Papeak [ms] 75.77 ± 21.94 64.12 ± 23.24 0.305
TEMA [ms] 98.66 ± 22.89 97.87 ± 19.98 0.941
Left atrial anterior wall
Pastart [ms] 69.55 ± 16.80 67.50 ± 16.30 0.802
Papeak [ms] 85.66 ± 15.26 87.25 ± 13.39 0.824
TEMA [ms] 131.56 ± 67.97 108.50 ± 15.21 0.364
Left atrial inferior wall
Pastart [ms] 57.11 ± 24.96 53.87 ± 19.21 0.771
Papeak [ms] 78.55 ± 23.11 70.25 ± 20.88 0.451
TEMA [ms] 109.11 ± 23.97 96.62 ± 15.86 0.231
Left atrial posterior wall
Pastart [ms] 62.11 ± 25.42 46.87 ± 12.47 0.146
Papeak [ms] 75.66 ± 30.95 60.87 ± 9.99 0.217
TEMA [ms] 104.67 ± 22.38 83.12 ± 6.10 0.019
Values are presented as mean ± SD; DM — diabetes; Pastart — the time between the beginning of the P-wave on the monitor’s ECG to the start of
the a’ wave on the DTE-curve profile; Papeak — the time between the beginning of the P-wave on the monitor’s ECG to the peak of the a’ wave on
the DTE-curve profile; TEMA — total electromechanical activity
Table 1. Basic characteristics and atrial mechanical functions.
DM group (n = 8) Control group (n = 8) P
Gender (male/female) 4/4 3/5 1.00
Weight [kg] 2.29 ± 0.47 2.19 ± 0.17 0.55
Glucose level at 8 W [mmol/L] 16.35 ± 3.44 5.81 ± 0.81 < 0.001
LAD [mm] 8.28 ± 0.58 6.75 ± 0.59 < 0.001
IVST [mm] 2.95 ± 0.54 1.91 ± 0.20 < 0.001
LVPWT [mm] 2.98 ± 0.39 1.92 ± 0.17 < 0.001
LVEDD [mm] 11.86 ± 0.75 12.27 ± 1.33 0.44
LVESD [mm] 7.55 ± 1.21 7.71 ± 1.20 0.16
LV ejection fraction [%] 71.33 ± 5.52 73.00 ± 5.04 0.53
LA maximal volume [mL/m2] 0.48 ± 0.09 0.45 ± 0.17 0.64
LA minimal volume [mL/m2] 0.17 ± 0.08 0.14 ± 0.06 0.40
LA P-wave volume [mL/m2] 0.25 ± 0.10 0.21 ± 0.07 0.34
LA ejection fraction [%] 59.44 ± 6.04 59.12 ± 8.62 0.93
LA active emptying [%] 34.66 ± 6.63 33.87 ± 7.60 0.82
RA maximal volume [mL/m2] 0.29 ± 0.13 0.29 ± 0,12 0.93
RA minimal volume [mL/m2] 0.16 ± 0.06 0.12 ± 0.05 0.20
RA P-wave volume [mL/m2] 0.22 ± 0.06 0.16 ± 0.09 0.16
RA ejection fraction [%] 47.33 ± 9.72 52.5 ± 3.63 0.37
RA active emptying [%] 23.55 ± 5.70 30.62 ± 8.01 0.05
E velocity [cm/s] 46.77 ± 15.25 64.75 ± 3.38 0.07
A velocity [cm/s] 51.77 ± 12.71 54.95 ± 18.92 0.68
E/A 1.29 ± 0.64 0.99 ± 0.31 0.43
E/e’ 9.03 ± 2.77 10.29 ± 4.33 0.26
Values are mean ± SD; DM — diabetes; LAD — left atrial diameter; IVST — interventricular septal thickness; LVPWT — left ventricular posterior wall thickness;
LVEDD — left ventricular end-diastolic dimension; LVESD — left ventricular end-systolic dimension; LV — left ventricular; LA — left atrial; RA — right atrial;
E velocity — early diastolic velocity of mitral inflow; A velocity — late diastolic velocity of mitral inflow; e’ — early diastolic velocity of septal mitral annulus
64
Cardiology Journal 2013, Vol. 20, No. 1
www.cardiologyjournal.org
Table 3. Hemodynamic and electrophysiological studies.
DM (n = 8) Control (n = 8) P
SBP [mm Hg] 119.5 ± 6.83 124.7 ± 10.23 0.3
DBP [mm Hg] 102.16 ± 4.79 97.12 ± 7.60 0.18
LVEDP [mm Hg] –5.80 ± 8.10 –8.57 ± 3.59 0.436
HR [bpm] 152.33 ± 33.99 169.89 ± 16.31 0.182
IACT [ms] 37.66 ± 8.88 27.70 ± 2.12 0.005
AVWCL [ms] 186.00 ± 44.81 165.44 ± 9.28 0.197
HRAERP [m]s 98.00 ± 28.96 81.55 ± 5.83 0.115
HLAERP [ms] 99.12 ± 34.39 79.11 ± 7.88 0.109
LLAERP [ms] 104.12 ± 38.67 82.44 ± 12.12 0.130
AERPD [ms] 28.37 ± 7.52 11.62 ± 5.60 < 0.001
Values are mean ± SD, DM — diabetes; SBP — systolic blood pressure, DBP — diastolic blood pressure, LVEDP — left ventricular end diastolic pressure,
HR — heart rate; IACT — interatrial conduction time; AVWCL — Wenckebach cycle length of A-V conduction; HRAERP — high right atrial effective
refractory period; HLAERP — high left atrial effective refractory period; LLAERP — low left atrial effective refractory period; AERPD — atrial effective
refractory periods dispersion
Figure 2. Atrial fibrillation (AF) inducibility in both groups; A. Representative AF episode induced during Burst pacing
in diabetes mellitus group; B. Inducibility of AF in both groups; C. Comparison of the inducibility of AF between
the diabetes group and controls; n = 8 in each group; p < 0.01; HRA — high right atrium; HLA — high left atrium.
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Figure 3. Histological examinations on left atrial fibrosis in both groups; A, B. Representative Sirius-Red staining of
the two groups; C. Comparsion of the mean percentage of left atrial interstitial fibrosis in each group. Data are
presented as mean ± SD; n = 8 in each group; *p < 0.01.
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Relationship between atrial interstitial
fibrosis and atrial electromechanical function
Correlation analysis showed that RA wall
Pastart, Papeak and TEMA, LA lateral wall Papeak
and TEMA, LA posterior wall TEMA, LA inferior
wall TEMA, blood glucose levels, IACT were corre-
lated with atrial areas of fibrosis (r = 0.507, p < 0.05;
r = 0.539, p < 0.05; r = 0.630, p < 0.01; r = 0.517,
p < 0.05; r = 0.515, p < 0.05; r = 0.700, p < 0.01;
r = 0.576, p < 0.05; r = 0.700, p < 0.01; r = 0.606,
p < 0.05, respectively) (Fig. 4). Correlation analy-
sis also showed that inter-atrial septum Pastart, LA
posterior wall Pastart and LA posterior wall Papeak
were correlated with IACT (r = 0.634, 0.562, 0.629,
respectively, p < 0.05).
Discussion
Major findings
The major findings of the present study were
as follows: (1) Atrial electromechanical dysfunction
was present in the alloxan-induced diabetic rabbits.
Figure 4. Relationship between atrial interstitial fibrosis and atrial electromechanical function; TEMA — total electro-
mechanical activity; LAT — left atrial lateral wall; Papeak — Pa’-peak interval; RA — right atrial wall; POST — left
atrial posterior wall; INF — left atrial inferior wall
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(2) Alloxan-induced diabetic rabbit atria showed
structural remodeling characterized by diffuse inter-
stitial fibrosis. (3) Atrial electrophysiological chang-
es in diabetic hearts included prolonged interatrial
electrical conduction and increased AERP disper-
sion. (4) Impaired atrial electromechanical function,
LA interstitial fibrosis and interatrial electrical con-
duction delay were correlated, and may constitute
a substrate for the development of AF in diabetic atria.
Atrial electromechanical dysfunction
in diabetes mellitus
Previous studies have showed that intra- and
interatrial electromechanical coupling and atrial
EMD, measured by TDI, were increased in patients
with paroxysmal AF and type 1 DM compared with
healthy controls [8, 15]. These data suggest that
increased interatrial EMD might be related to an
increased risk of AF [8, 15]. Acar et al. [15] evalu-
ated atrial electromechanical coupling obtained by
TDI in patients with type 1 DM, indicating that in-
tra- and inter-atrial EMD are prolonged, whereas
diastolic functions of both ventricles and LA me-
chanical functions are impaired in patients with type
1 DM. However, intra- and inter-atrial conduction
times were not investigated by electrophysiologi-
cal techniques. Our present study also showed that
atrial electromechanical function were impaired in
diabetic rabbits. In particular, the parameters re-
garding atrial electromechanical function were
closely related to the extent of atrial interstitial fi-
brosis and interatrial electrical conduction time. To
the best of our knowledge, our study was the first
to evaluate the potential relationship between the
echocardiographic LA electromechanical function,
atrial interstitial fibrosis and interatrial electrical
conduction delay in diabetic rabbit hearts.
Atrial mechanical functions
in diabetes mellitus
A recent study indicated LA mechanical func-
tion measured by LA total emptying fraction is
a predictor for the development of post-operative
AF following cardiac surgery [16]. Additionally, the
atrial emptying pattern is strongly affected by LV
diastolic properties [17, 18]. It has been demonstrat-
ed that in diabetic patients, decreased LA passive
emptying volume is related to increased LVEDP
and increased LA active emptying volume is asso-
ciated with compensatory mechanisms in LA con-
traction [15]. However, in present study, diastolic
and systolic dysfunction of LV and systolic dysfunc-
tion of LA were not observed. Moreover, hemody-
namic parameters, such as the DBP and LVEDP
were slightly increased in DM group. Therefore, we
speculate that diabetic atrial mechanical dysfunc-
tion at 8 week was too slight to be detected by
echocardiography.
Atrial substrate and remodeling
in diabetes mellitus
Atrial remodeling involves changes in the
structure, function and geometry of the atria, modi-
fication of atrial electrical and contractile properties,
and changes in the amount and the composition of
the extracellular matrix [19, 20]. Together, these
alterations create an arrhythmogenic substrate es-
sential for the onset and persistence of AF. Struc-
tural remodeling results in electrical tissue non-ho-
mogeneity, slowed conduction and electrical uncou-
pling, facilitating AF continuation without inducing
changes in atrial action potential properties.
The potential mechanisms for diabetes-induced
atrial remodeling were not fully understood. It was
supposed that inflammation, oxidative stress acti-
vation, autonomic imbalance were observed in dia-
betic pathophysiological state, which may promote
the development of AF. Also angiotensin 1 recep-
tor activity was upregulated in diabetic hearts [21],
and this receptor was coupled with transforming
growth factor-beta1 and lead to atrial fibrosis [22].
Kato et al. [23] showed that inter-atrial conduction
delay and increased fibrotic deposition in atrium
play a major role in producing atrial arrhythmoge-
nicity in genetic type 2 DM rats, which indicated
that atrial structural remodeling characterized by
extensive interstitial fibrosis may be one of the
major mechanisms of AF development in diabetic
heart. Another study [24] from this group demon-
strated that activation of advanced glycation end
products and its receptor was associated with dif-
fuse atrial interstitial fibrosis in streptozotocin-in-
duced diabetic rats. The present study showed that
impaired LA electromechanical function along with
extensive atrial fibrosis and increased inter-atrial
conduction delay were related to increased induc-
ibility of AF. Also, our results also indicated that
AERP dispersion was increased in DM rabbits, sug-
gesting that heterogeneity of repolarization is an
electrophysiological change in this setting. Howev-
er, the molecular mechanisms for DM-induced atrial
electromechanical dysfunction and atrial remodel-
ing should be investigated in future studies. Fur-
ther studies on atrial electromechanical function
may be of special value to assess the impact of novel
thearpeutic interventions anti-remodeling effects
such as glitazones [25] on prevention and treatment
of AF.
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Limitations of the study
There are several limitations in the present
study. First, tissue Doppler measurements depend
on skills of the person performing the examinations
and need suitable acoustic window to carry out regi-
strations of acceptable quality. We have to take into
account the intrinsic limitations of the technique,
such as dependency on the angle of incidence, the
variable position of the sample volume during the
cardiac cycle, and the complex movement of the
analyzed segment. Heart rate and small heart of the
rabbit may affect the imaging quality of our study.
Second, we do not have data on the successive elec-
trophysiological and structural changes over time
as well as on the temporal relationship between the
two types of remodeling. Another limitation is that
we did not assess the possible paradoxical response
of AERP to increased heart rates which is another
characteristic of electrical remodeling. Finally, the
molecular mechanisms for DM-induced electrical
and structural remodeling should be further inves-
tigated in future studies.
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